Enhancing the incorporation of the patient’s voice in drug development and evaluation

Enhancing the incorporation of the patient’s voice in drug development and evaluation

Plain English summary People living with a condition are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation. In 2012, the U.S. Food and Drug Administration (FDA) established the Patient-Focused Drug Development (PFDD) initiative to more sys...

Full description

Bibliographic Details
Main Authors: Meghana Chalasani, Pujita Vaidya, Theresa Mullin
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Research Involvement and Engagement
Subjects:
Patient-focused drug development
Patient engagement
Patient perspectives
FDA
Benefit-risk
Online Access:http://link.springer.com/article/10.1186/s40900-018-0093-3

Internet

http://link.springer.com/article/10.1186/s40900-018-0093-3

Similar Items